[HTML][HTML] Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang, H Oh… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment.
CH Lee, YB Lee, MA Kim, H Jang, H Oh… - Clinical and …, 2020 - europepmc.org
Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
[HTML][HTML] Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang, H Oh… - Clinical and Molecular …, 2020 - e-cmh.org
Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang… - Clinical and …, 2020 - snucm.elsevierpure.com
Background/Aims: Several treatment options are currently available for patients with
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
C Lee, MA Kim, H Oh, EJ Cho, J Lee… - Clinical and Molecular …, 2020 - kiss.kstudy.com
Background/Aims: Several treatment options are currently available for patients with
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH LEE, YB LEE, MA KIM, H JANG… - Clinical and …, 2020 - pesquisa.bvsalud.org
Background/Aims@# Several treatment options are currently available for patients with
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MS Kim, HJ Jang… - Clinical and …, 2020 - oldkmbase.medric.or.kr
Background/Aims: Several treatment options are currently available for patients with
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
[HTML][HTML] Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang, H Oh… - Clinical and Molecular …, 2020 - e-cmh.org
Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang, H Oh, SW Kim… - Clinical and Molecular … - KoreaMed
Methods Consecutive HCC patients who received regorafenib or nivolumab after failure of
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
sorafenib treatment were included. Primary endpoint was overall survival (OS) and …
[PDF][PDF] Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment
CH Lee, YB Lee, MA Kim, H Jang, H Oh, SW Kim… - 2020 - pdfs.semanticscholar.org
Background/Aims: Several treatment options are currently available for patients with
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …
hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare …